The Sift Here’s what we’re Sifting today

Trial underway for possible cancer cure

by Kent Covington
Posted 11/07/19, 11:18 am

Doctors have safely administered the first U.S. test of a cancer treatment made using the CRISPR gene-editing tool for human patients. It’s too soon to say whether it will cure the disease, the doctors said Wednesday, but cancer specialists said the results made them hopeful.

How does the treatment work? The doctors took immune cells from the patients’ blood. They deleted three genes that might have been hindering the cells’ ability to attack the cancer and added a new, fourth feature, a form of immunotherapy. The treatment does not change DNA inside the body, but it removes, alters, and returns cells that are supercharged to fight cancer. After two to three months, one patient’s cancer continued to worsen and another’s was stable. The study showed minimal and manageable side effects. The third patient was treated too recently to know how she’ll fare. The doctors plan to treat 15 more patients to assess the treatment’s safety and effectiveness.

Dig deeper: Read Sophia Lee’s interview with bioethicist William Hurlbut about less ethical uses of CRISPR.

Read more from The Sift Sign up for The Sift email
Kent Covington

Kent is a reporter and news anchor for WORLD Radio. He spent nearly two decades in Christian and news/talk radio before joining WORLD in 2012. He resides in Atlanta, Ga. Follor him on Twitter @kentcovington.

Read more from this writer


You must be a WORLD Member and logged in to the website to comment.